Niraparib + Dostarlimab + RT in Pancreatic Cancer

Clinical trial NCT04409002 · COMPLETED

Trial details

NCT number: NCT04409002
Sponsor: Massachusetts General Hospital
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Pancreatic Cancer Metastatic Pancreatic Cancer

Start date: 2020-07-23
Primary completion: 2022-01-19
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.